Chi Advisors LLC Orchard Therapeutics PLC Transaction History

Chi Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.45 - $0.69 $1.21 Million - $1.85 Million	2,679,645 Added 50.49%	7,987,396 $3.99 Million
Q1 2022 May 16, 2022	SELL	$0.7 - $1.51 $799,473 - $1.72 Million	-1,142,105 Reduced 17.71%	5,307,751 $3.78 Million
Q4 2021 Feb 11, 2022	BUY	$1.16 - $2.23 $2.75 Million - $5.28 Million	2,367,884 Added 58.01%	6,449,856 $8.51 Million
Q2 2021 Aug 11, 2021	BUY	$4.39 - $7.23 $131,700 - $216,900	30,000 Added 0.74%	4,081,972 $17.9 Million
Q1 2021 May 14, 2021	BUY	$4.39 - $9.08 $4.92 Million - $10.2 Million	1,120,787 Added 38.24%	4,051,972 $29.4 Million
Q2 2020 Aug 12, 2020	SELL	$5.75 - $11.99 $178,721 - $372,673	-31,082 Reduced 1.05%	2,931,185 $17.6 Million
Q1 2020 May 14, 2020	BUY	$5.65 - $15.71 $21,328 - $59,305	3,775 Added 0.13%	2,962,267 $22.3 Million
Q4 2019 Feb 14, 2020	SELL	$10.15 - $15.58 $321,947 - $494,182	-31,719 Reduced 1.06%	2,958,492 $40.7 Million
Q3 2019 Nov 12, 2019	BUY	$11.88 - $16.72 $35.5 Million - $50 Million	2,990,211 New	2,990,211 $35.5 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Chi Advisors LLC with notifications on news.